Now showing items 1-14 of 14
| Keywords |
|---|
| access [1] |
| Allogeneic [1] |
| biomarker [5] |
| cost-effectiveness [2] |
| Farmacoeconomy [1] |
| Hematopoietic cell transplant [1] |
| immunotherapy [5] |
| Late effects [1] |
| nivolumab [1] |
| PD-L1 [2] |
| Personalized Medicine [2] |
| pooled analysis [1] |
| Severe aplastic anemia [1] |
| Survivorship [1] |
Now showing items 1-14 of 14